Skip to main content
Top
Published in: Rheumatology International 12/2012

01-12-2012 | Original Article

Identification of forty cases with alkaptonuria in one village in Jordan

Authors: Mohammed Al-sbou, Nesrin Mwafi, Mohammad Abu Lubad

Published in: Rheumatology International | Issue 12/2012

Login to get access

Abstract

Alkaptonuria (AKU) is one of the four initially identified inborn errors of metabolism. The prevalence of AKU is unknown in Jordan. Therefore, a research project was started in April 2009 at the Faculty of Medicine/Mutah University in southern Jordan. The aims of the project were to identify people with AKU, to screen all family members with history of AKU, and to increase the awareness about the disease among health care professionals and the community in southern Jordan. Targeted family screening method was used to identify patients with AKU. In this paper, we present preliminary results of screening 17 families with history of AKU in a single village in southern region of Jordan. Forty cases with AKU were identified in this village (age range, 1–60 years). Early cases with AKU were diagnosed through out this study, two-third of patients (n = 28) were under the age of thirty. Interestingly, nine cases with AKU were identified in one family. Our experience suggests that for the identification of cases with AKU where consanguinity is common, the focus for screening should be extended to all family members. The prevalence of AKU among Jordanian is likely to be greater than the prevalence rates worldwide due to high rates of consanguineous marriages. Further studies and effective screening programs are needed to detect undiagnosed cases of AKU, to provide genetic counseling, and ultimately to prevent the occurrence of new cases of AKU in Jordan.
Literature
1.
go back to reference Fernandez-Canon JM, Granadino B, Beltran-Valero de Bernabe D, Renedo M, Fernandez-Ruiz E, Penalva MA et al (1996) The molecular basis of alkaptonuria. Nat Genet 14(1):19–24PubMedCrossRef Fernandez-Canon JM, Granadino B, Beltran-Valero de Bernabe D, Renedo M, Fernandez-Ruiz E, Penalva MA et al (1996) The molecular basis of alkaptonuria. Nat Genet 14(1):19–24PubMedCrossRef
2.
go back to reference La Du BN, Zannoni VG, Laster L, Seegmiller JE (1958) The nature of the defect in tyrosine metabolism in alcaptonuria. J Biol Chem 230(1):251–260PubMed La Du BN, Zannoni VG, Laster L, Seegmiller JE (1958) The nature of the defect in tyrosine metabolism in alcaptonuria. J Biol Chem 230(1):251–260PubMed
3.
go back to reference Zannoni VG, Lomtevas N, Goldfinger S (1969) Oxidation of homogentisic acid to ochronotic pigment in connective tissue. Biochim Biophys Acta 177(1):94–105PubMedCrossRef Zannoni VG, Lomtevas N, Goldfinger S (1969) Oxidation of homogentisic acid to ochronotic pigment in connective tissue. Biochim Biophys Acta 177(1):94–105PubMedCrossRef
4.
go back to reference Wilke A, Steverding D (2009) Ochronosis as an unusual cause of valvular defect: a case report. J Med Case Reports 3:9302CrossRef Wilke A, Steverding D (2009) Ochronosis as an unusual cause of valvular defect: a case report. J Med Case Reports 3:9302CrossRef
6.
go back to reference Wolff JA, Barshop B, Nyhan WL, Leslie J, Seegmiller JE, Gruber H et al (1989) Effects of ascorbic acid in alkaptonuria: alterations in benzoquinone acetic acid and an ontogenic effect in infancy. Pediatr Res 26(2):140–144PubMedCrossRef Wolff JA, Barshop B, Nyhan WL, Leslie J, Seegmiller JE, Gruber H et al (1989) Effects of ascorbic acid in alkaptonuria: alterations in benzoquinone acetic acid and an ontogenic effect in infancy. Pediatr Res 26(2):140–144PubMedCrossRef
7.
go back to reference Mayatepek E, Kallas K, Anninos A, Muller E (1998) Effects of ascorbic acid and low-protein diet in alkaptonuria. Eur J Pediatr 157(10):867–868PubMedCrossRef Mayatepek E, Kallas K, Anninos A, Muller E (1998) Effects of ascorbic acid and low-protein diet in alkaptonuria. Eur J Pediatr 157(10):867–868PubMedCrossRef
8.
go back to reference El-Khushman HM (2007) Clinical quiz. A 69-year-old man with a thick dark pigmentation on his hands, and low back pain. Saudi Med J 28(11):1761–1762PubMed El-Khushman HM (2007) Clinical quiz. A 69-year-old man with a thick dark pigmentation on his hands, and low back pain. Saudi Med J 28(11):1761–1762PubMed
9.
go back to reference Stenn FF, Milgram JW, Lee SL, Weigand RJ, Veis A (1977) Biochemical identification of homogentisic acid pigment in an ochronotic Egyptian mummy. Science 197(4303):566–568PubMedCrossRef Stenn FF, Milgram JW, Lee SL, Weigand RJ, Veis A (1977) Biochemical identification of homogentisic acid pigment in an ochronotic Egyptian mummy. Science 197(4303):566–568PubMedCrossRef
10.
go back to reference Idem (1908) The Croonian lectures on inborn errors of metabolism. Lecture II. Alkaptonuria. Lancet 2:73–79 Idem (1908) The Croonian lectures on inborn errors of metabolism. Lecture II. Alkaptonuria. Lancet 2:73–79
11.
go back to reference Milch RA (1960) Studies of alcaptonuria: inheritance of 47 cases in eight highly inter-related dominican kindreds. Am J Hum Genet 12(1):76–85PubMed Milch RA (1960) Studies of alcaptonuria: inheritance of 47 cases in eight highly inter-related dominican kindreds. Am J Hum Genet 12(1):76–85PubMed
12.
go back to reference Srsen S, Cisarik F, Pasztor L, Harmecko L (1978) Alkaptonuria in the Trencin district of Czechoslovakia. Am J Med Genet 2(2):159–166PubMedCrossRef Srsen S, Cisarik F, Pasztor L, Harmecko L (1978) Alkaptonuria in the Trencin district of Czechoslovakia. Am J Med Genet 2(2):159–166PubMedCrossRef
13.
go back to reference Zatkova A, de Bernabe DB, Polakova H, Zvarik M, Ferakova E, Bosak V et al (2000) High frequency of alkaptonuria in Slovakia: evidence for the appearance of multiple mutations in HGO involving different mutational hot spots. Am J Hum Genet 67(5):1333–1339PubMed Zatkova A, de Bernabe DB, Polakova H, Zvarik M, Ferakova E, Bosak V et al (2000) High frequency of alkaptonuria in Slovakia: evidence for the appearance of multiple mutations in HGO involving different mutational hot spots. Am J Hum Genet 67(5):1333–1339PubMed
14.
go back to reference Tadmouri GO, Nair P, Obeid T, Al Ali MT, Al Khaja N, Hamamy HA (2009) Consanguinity and reproductive health among Arabs. Reprod Health 6:17PubMedCrossRef Tadmouri GO, Nair P, Obeid T, Al Ali MT, Al Khaja N, Hamamy HA (2009) Consanguinity and reproductive health among Arabs. Reprod Health 6:17PubMedCrossRef
16.
go back to reference John SS, Padhan P, Mathews JV, David S (2009) Acute anterior uveitis as the initial presentation of alkaptonuria. J Postgrad Med 55(1):35–37PubMedCrossRef John SS, Padhan P, Mathews JV, David S (2009) Acute anterior uveitis as the initial presentation of alkaptonuria. J Postgrad Med 55(1):35–37PubMedCrossRef
Metadata
Title
Identification of forty cases with alkaptonuria in one village in Jordan
Authors
Mohammed Al-sbou
Nesrin Mwafi
Mohammad Abu Lubad
Publication date
01-12-2012
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 12/2012
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-011-2219-x

Other articles of this Issue 12/2012

Rheumatology International 12/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine